Saturday, June 13, 2026

Bluff or Breakthrough—Doubts Grow Over Trump’s China Claims

Trump's claims of ongoing China negotiations are likely false, aimed at calming markets amid tariff threats, per NYT report.

Palantir’s 24% Drop in 5 Days Linked to DoD Budget Cuts, Despite AI Sector Growth

Palantir Technologies' stock dropped 10% after DoD budget cuts, highlighting its reliance on government contracts amidst an AI boom.

South Korea vs. China: The Battle for TV Market Supremacy

South Korea and China solidify their dominance in the global TV market, with Chinese firms surpassing Japanese companies.

Tag: John Rim

Samsung Biologics CEO John Rim Poised for Third Term: What This Means for the Global CDMO Market in 2026

John Rim of Samsung Biologics aims for a third term, leading record growth and expansion into next-gen therapies amid global challenges.

Top News

- Our Sponsors Ad -

Follow us